169
Views
12
CrossRef citations to date
0
Altmetric
Clinical Communication

Anaesthesia of a Sumatran tiger on eight occasions with ketamine, medetomidine and isoflurane

, &
Pages 105-108 | Accepted 29 Mar 1999, Published online: 22 Feb 2011
 

Abstract

Case. An 18-month-old male Sumatran tiger was referred for endoscopy and dilatation of an oesophageal stricture. Anaesthesia and bouginage was undertaken on eight occasions 2-3 weeks apart to dilate the oesophageal stricture.

Clinical findings. On the first occasion, sedation was induced with a combination of medetomidine (30 𝛍/gkg) and ketamine (2.35 mg/kg) given intramuscularly. Cardiopulmonary depression (chararcterised by bradycardia, ventricular arrhythmias, hypoventilation and cyanosis) was severe and in subsequent anaesthesias the medetomidine dose was decreased to about 18 𝛍g/kg and the ketamine dose increased to about 3 𝛍g/kg given intramuscularly. Immobilisation was adequate and the severity of the cardiopulmonary depression was reduced at the revised drug dosages. Atipamezole was effective in reversing both the cardiopulmonary and central nervous system depression.

Conclusion. The dosage of medetomidine and ketamine recommended in the literature for immobilising tigers produced severe cardiopulmonary depression in this animal. A reduced dosage of medetomidine and higher dosage of ketamine provided adequate restraint with decreased cardiopulmonary depression.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.